Compounds > levamisole
Page last updated: 2024-08-23

levamisole and Disease Exacerbation

levamisole has been researched along with Disease Exacerbation in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's4 (50.00)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ge, M; Huang, J; Huang, Z; Li, X; Nie, N; Shao, Y; Shi, J; Wang, M; Zhang, J; Zheng, Y1
Hassani, B; Khoury, CA; Nelson, NW1
Choi, GS; Jun, SH; Kang, BM; Lim, KH; Park, IJ1
Choudhary, B; Hegde, M; Karki, SS; Kumar, S; Panjamurthy, K; Raghavan, SC; Ranganatha, SR; Rangappa, KS; Thomas, E1
Agnese, V; Bazan, V; Calò, V; Cicero, G; Colucci, G; Corsale, S; Dardanoni, G; Gebbia, N; Grassi, N; Latteri, MA; Russo, A; Tomasino, RM; Valerio, MR; Vieni, S1
Agarwal, S; Khandpur, S; Pal, H; Pandey, RM; Ramam, M; Sharma, VK1
Creagan, ET; Kardinal, CG; Maples, WJ; Marks, RS; Marschke, RF; Rowland, KM; Suman, VJ1
Buzogány, I; Döbrönte, R; Fazekas, A; Kaiser, L; Magyarlaki, T; Nagy, J; Simon, B; Sükösd, F1

Trials

2 trial(s) available for levamisole and Disease Exacerbation

ArticleYear
A randomized placebo-controlled double-blind study of levamisole in the treatment of limited and slowly spreading vitiligo.
    The British journal of dermatology, 2005, Volume: 153, Issue:1

    Topics: Adult; Child; Dermatologic Agents; Disease Progression; Double-Blind Method; Female; Humans; Levamisole; Male; Psychometrics; Quality of Life; Severity of Illness Index; Treatment Outcome; Vitiligo

2005
Phase II study of combined levamisole with recombinant interleukin-2 in patients with advanced malignant melanoma.
    American journal of clinical oncology, 1997, Volume: 20, Issue:5

    Topics: Adjuvants, Immunologic; Administration, Oral; Adult; Aged; Confidence Intervals; Disease Progression; Female; Humans; Immunotherapy, Adoptive; Injections, Subcutaneous; Interleukin-2; Killer Cells, Lymphokine-Activated; Levamisole; Male; Melanoma; Middle Aged; Pain; Recombinant Proteins; Remission Induction; Sleep Stages; Survival Rate; Treatment Outcome; Treatment Refusal; Vomiting

1997

Other Studies

6 other study(ies) available for levamisole and Disease Exacerbation

ArticleYear
Cyclosporine Combined with Levamisole for Lower-Risk Myelodysplastic Syndromes.
    Acta haematologica, 2015, Volume: 134, Issue:3

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Child; Cyclosporine; Disease Progression; Female; Humans; Levamisole; Male; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies; Survival Analysis; Young Adult

2015
Woman With Progressively Worsening Retiform Purpura.
    Annals of emergency medicine, 2017, Volume: 69, Issue:2

    Topics: Adult; Diagnosis, Differential; Disease Progression; Female; Humans; Levamisole; Purpura; Vasculitis, Leukocytoclastic, Cutaneous

2017
Laparoscopic resection of extraperitoneal rectal cancer: a comparative analysis with open resection.
    Surgical endoscopy, 2009, Volume: 23, Issue:8

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Elective Surgical Procedures; Female; Fluorouracil; Follow-Up Studies; Humans; Laparoscopy; Laparotomy; Levamisole; Male; Middle Aged; Neoplasm Invasiveness; Postoperative Complications; Prospective Studies; Radiotherapy, Adjuvant; Rectal Neoplasms; Tegafur; Treatment Outcome

2009
Novel levamisole derivative induces extrinsic pathway of apoptosis in cancer cells and inhibits tumor progression in mice.
    PloS one, 2012, Volume: 7, Issue:9

    Topics: Animals; Apoptosis; Biomarkers, Tumor; Cell Death; Cell Line, Tumor; Cell Proliferation; Disease Progression; DNA Damage; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Leukemia; Levamisole; Mice; Models, Biological; Reactive Oxygen Species; Signal Transduction

2012
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16 Suppl 4

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease Progression; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Mutation; Neoplasm Staging; Prospective Studies; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Tumor Suppressor Protein p53

2005
Prognostic histological and immune markers of renal cell carcinoma.
    Pathology oncology research : POR, 2001, Volume: 7, Issue:2

    Topics: Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Carcinoma, Renal Cell; Combined Modality Therapy; Disease Progression; Follow-Up Studies; Humans; Immunoenzyme Techniques; Immunologic Factors; Immunotherapy; Interferon alpha-2; Interferon-alpha; Kidney Neoplasms; Levamisole; Lymphocytes, Tumor-Infiltrating; Neoplasm Proteins; Neoplasm Staging; Nephrectomy; Prognosis; Recombinant Proteins; Treatment Outcome; Vinblastine

2001